BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 1,010,000 shares, a growth of 927.5% from the February 29th total of 98,300 shares. Based on an average daily trading volume, of 378,600 shares, the days-to-cover ratio […]
BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) CEO Peter Altman acquired 108,108 shares of the stock in a transaction that occurred on Tuesday, February 13th. The shares were acquired at an average cost of $0.46 per share, with a total value of $49,729.68. Following the transaction, the chief executive officer now owns 555,447 shares in […]
BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) major shareholder Phillip Md Et Al Frost sold 129,802 shares of BioCardia stock in a transaction on Friday, January 19th. The stock was sold at an average price of $0.43, for a total transaction of $55,814.86. Following the completion of the transaction, the insider now owns 1,896,025 shares […]
BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) major shareholder Phillip Md Et Al Frost sold 129,802 shares of BioCardia stock in a transaction that occurred on Friday, January 19th. The stock was sold at an average price of $0.43, for a total value of $55,814.86. Following the transaction, the insider now owns 1,896,025 shares of […]
Shares of BioCardia, Inc. (NASDAQ:BCDAW – Get Free Report) rose 74.2% during mid-day trading on Monday . The company traded as high as $0.12 and last traded at $0.12. Approximately 667 shares changed hands during trading, a decline of 82% from the average daily volume of 3,704 shares. The stock had previously closed at $0.07. […]